FindTrial
Sign In

A clinical trial to study the effects of two drugs Hamdoroid Capsule and Hamdoroid Ointment in patients with Piles

Clinical Evaluation of the Efficacy of Hamdoroid Capsule and Hamdoroid Ointmenton I and II degree haemorrhoids

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000789
Enrollment
Unknown
Registered
2009-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hamdoroid capsule and Hamdoroid Ointment: Hamdoroid capsule 1000 mg twice daily and Hamdoroid Ointment to be applied locally twice daily Control Intervention1: Placebo: Qurs Placebo 100

Sponsors

Hamdard National Foundation, New Delhi
Lead Sponsor
Jamia Hamdard, New Delhi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: I and II degree hemorrhoids diagnosed by Proctoscopic Examination both sex age between 18 and 60 years

Exclusion criteria

Exclusion criteria: III and IV degree hemorrhoids Any other active anorectal diseases Pregnant and Lactating women

Design outcomes

Primary

MeasureTime frame
Arrest of Bleeding, Relief in pain, Itching and constipationTimepoint: 4, 8, 12 weeks—

Secondary

MeasureTime frame
Improvement in general health and patients' satisfactionTimepoint: 3 months—

Countries

India

Contacts

Public ContactYasmeen Shamsi
yasmeen.ijum@gmail.com011-26059692, Ext. 5930, 5723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026